Commit To Purchase OncoMed Pharmaceuticals At $5, Earn 14% Annualized Using Options
January 24, 2017 at 11:41 AM EST
Investors eyeing a purchase of OncoMed Pharmaceuticals Inc. (OMED) stock, but tentative about paying the going market price of $7.55/share, might benefit from considering selling puts among the alternative strategies at their disposal..